© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Quantitative analysis of the impact of neovascular age-related macular degeneration (AMD) on the UK population has led a team of researchers to call for urgent, early access to the new class of drug therapies for the disease.
Related Content:
Retina